Physicians and Pharma need to understand how this fast-developing technology will transform routine screening and modernize the adjuvant setting

Dr. Emma Ococks

Associate Consultant

Dr. Priya Kar


Dr. Luke Solon

Vice President

In this white paper, you will explore plasma-based testing and its:

  • role in early detection
  • potential to lead to new therapies in earlier lines of treatment and accelerated drug approvals
  • utility as a companion diagnostic in targeted therapy
  • current reimbursement landscape
  • potential benefits when integrated into routine clinical practice

For plasma-based testing to be fully incorporated into the clinic, physicians need to be educated about this testing method. The effectiveness of physician engagement campaigns will significantly influence the integration of this technology into the clinic.

Download your free copy of the white paper by completing the form.